PEOPLE - CardioVascular Dynamics makes promotion:
This article was originally published in Clinica
CardioVascular Dynamics has promoted its vice-president of sales and marketing, Jeffrey O'Donnell, to the post of president and chief operating officer. His predecessor Michael Henson continues in his current position of chairman and chief executive officer of the US of coronary stent manufacturer.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.